Relay Therapeutics, Inc.
2020 Q3 - 2025 Q4 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 9,616 | 0.0% | 1,136,702 | 12/31/2025 |
| 2025 Q3 | 11/10/2025 | 5,801 | 0.0% | 1,111,331 | 9/30/2025 |
| 2025 Q2 | 8/12/2025 | 3,828 | 0.0% | 1,106,260 | 6/30/2025 |
| 2025 Q1 | 9/15/2025 | 2,790 | 0.0% | 1,064,858 | 3/31/2025 |
| 2024 Q4 | 2/6/2025 | 4,165 | 0.0% | 1,010,807 | 12/31/2024 |
| 2024 Q3 | 11/12/2024 | 7,333 | 0.0% | 1,035,789 | 9/30/2024 |
| 2024 Q2 | 8/12/2024 | 5,355 | 0.0% | 821,391 | 6/30/2024 |
| 2024 Q1 | 5/9/2024 | 7,571 | 0.0% | 912,157 | 3/31/2024 |
| 2023 Q4 | 2/6/2024 | 9,665 | 0.0% | 877,813 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 6,012 | 0.0% | 714,805 | 9/30/2023 |
| 2023 Q2 | 8/10/2023 | 8,445 | 0.0% | 672,394 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 10,769 | 0.0% | 653,882 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 9,777 | 0.0% | 654,443 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 13,847 | 0.0% | 618,967 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 9,137 | 0.0% | 545,484 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 16,300 | 0.0% | 544,590 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 16,216 | 0.0% | 528,018 | 12/31/2021 |
| 2021 Q3 | 11/16/2021 | 13,505 | 0.0% | 428,322 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 8,159 | 0.0% | 222,970 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 6,714 | 0.0% | 194,191 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 6,632 | 0.0% | 159,563 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 6,604 | 0.0% | 155,043 | 9/30/2020 |